A new national trial is recruiting people with rare autoimmune diseases to measure their COVID-19 antibody response following at least 3 vaccinations.
The MELODY study is recruiting immunocompromised people to determine the antibody levels they develop in response to COVID-19 vaccination.
The MELODY study aims to:
- Assess how many immunocompromised people have detectable antibodies against COVID-19 following at least 3 vaccines;
- Investigate whether a lack of detectable antibodies is associated with risk of infection over a 6-month period;
- Investigate what factors are associated with lack of detectable antibodies in immunocompromised people.
Read more of this article
In her most recent blog about the changes in the healthcare landscape caused by the pandemic, our National Patient Champion, Ailsa Bosworth MBE reflects on how these changes will impact on the care of people with RA and Adult JIA. She considers how it has become even more important for those with these autoimmune conditions to be able to learn about their disease and acquire skills and coping strategies to enable better supported self-management, and Ailsa explains how NRAS can help with this.…
The British Society of Rheumatology recently published its
Important news for South Asian people with RA/PsA! NRAS has launched two new videos in Punjabi on the early inflammatory arthritis pathway which feature GP patient consultation and members of the multi-disciplinary team describing their roles. Please share widely.
Lord Black’s amendment to the Health and Care Bill calling for equal access to FLS
The updated rheumatology PIFU (Patient Initiated Follow-Up) guidance is now on NHS England and NHS Improvement’s 
Full information on the campaign plans can be found on Arthritis Action’s
Hope on the horizon for immuno-suppressed/compromised individuals
The Nuffield Foundation, in partnership with Versus Arthritis, has announced £4 million for new research funding to improve the social and economic wellbeing of people living with musculoskeletal conditions in the UK. Applicants should develop interdisciplinary proposals that can help identify, develop and enhance non-clinical policy and practice interventions.